XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible Assets
 9 Months Ended
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible Assets INTANGIBLE ASSETS
The following table provides a summary of the Company’s intangible assets:
  September 30, 2022 December 31, 2021
Estimated Useful LifeCost Accumulated
Amortization		CostAccumulated
Amortization
Technology
10 - 15 years
$55,712$15,634$55,712$12,720
Amortization expense of intangible assets was $971 for both the three months ended September 30, 2022 and 2021 and $2,914 and $1,936 for the nine months ended September 30, 2022 and 2021. Future amortization expense is projected as follows:
2022 (excluding the nine months ended September 30, 2022)
$739
20232,953
20242,953
20252,953
20262,953
2027 and thereafter
27,527
Total $40,078
During the third quarter 2021, the Company recorded an impairment charge of $82,300 to reduce the carrying value of the aMAZE IPR&D asset to $0 as a result of data from the aMAZE clinical trial not achieving statistical superiority.